CDX2 and prostate carcinoma: CDX2, CK20, β-catenin, PSA, P501S, and P504S may help to further differentiate prostate carcinoma from colon carcinomas in immunohistochemistry of poorly differentiated cancer involving the colorectal-prostatic region.[6,7] (Table 1)